The Medicines (Pharmacy and General Sale—Exemption) Amendment Order 1998

• Citation: S.I. 1998/107
• Sections: 5

Section 1 Citation, commencement and interpretation

(1) This Order may be cited as the Medicines (Pharmacy and General Sale—Exemption) Amendment Order 1998 and shall come into force on 13th February 1998.

(2) In this Order, “the principal Order ” means the Medicines (Pharmacy and General Sale—Exemption) Order 1980 .

Section 2 Amendment of Schedule 1 to the principal Order

After the paragraph numbered 1 in each of Columns 1, 2 and 3 of Part I of Schedule 1 to the principal Order there is inserted the paragraph numbered 1A as it appears in the corresponding column of the Schedule to this Order.

Section 1A

State registered chiropodists who hold a certificate of competence in the use of the medicines specified in Column 2 issued by or with the approval of the Chiropodists Board.

Section 1A

(a) The following prescription only medicines—

(i) Co-dydramol 10/500 tablets;

(ii) Amorolfine hydrochloride cream where the maximum strength of the Amorolfine in the cream does not exceed 0.25 per cent by weight in weight;

(iii) Amorolfine hydrochloride lacquer where the maximum strength of the Amorolfine in the lacquer does not exceed 5 per cent by weight in volume; and

(iv) Topical hydrocortisone where the maximum strength of the hydrocortisone in the medicinal product does not exceed 1 per cent by weight in weight; and

(b) Ibuprofen, other than preparations of ibuprofen which are prescription only medicines.

Section 1A

The sale or supply shall be only in the course of their professional practice, and the medicinal product must have been made up for sale or supply in a container elsewhere than at the place at which it is sold or supplied. The quantity to be sold or supplied to a person at any one time shall not exceed—

(a)

(i) in the case of Co-dydramol 10/500 tablets an amount sufficient for 3 days' treatment to a maximum of 24 tablets;

(b) in the case of Ibuprofen an amount sufficient for 3 days' treatment where the maximum dose is 400 mg, the maximum daily dose is 1,200 mg and the maximum pack size is 3,600 mg.